5LHR
The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody Nb22
Summary for 5LHR
Entry DOI | 10.2210/pdb5lhr/pdb |
Descriptor | Urokinase-type plasminogen activator, Camelid-Derived Antibody Fragment Nb22 (3 entities in total) |
Functional Keywords | trypsin-like serine proteases, nanobody, inhibitor, hydrolase |
Biological source | Mus musculus (House Mouse) More |
Cellular location | Secreted: P06869 |
Total number of polymer chains | 2 |
Total formula weight | 42816.83 |
Authors | Kromann-Hansen, T.,Lange, E.L.,Sorensen, H.P.,Ghassabeh, G.H.,Huang, M.,Jensen, J.K.,Muyldermans, S.,Declerck, P.J.,Andreasen, P.A. (deposition date: 2016-07-12, release date: 2017-06-28) |
Primary citation | Kromann-Hansen, T.,Louise Lange, E.,Peter Srensen, H.,Hassanzadeh-Ghassabeh, G.,Huang, M.,Jensen, J.K.,Muyldermans, S.,Declerck, P.J.,Komives, E.A.,Andreasen, P.A. Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator. Sci Rep, 7:3385-3385, 2017 Cited by PubMed: 28611361DOI: 10.1038/s41598-017-03457-7 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report